Ajaypal Singh to United States Food and Drug Administration
This is a "connection" page, showing publications Ajaypal Singh has written about United States Food and Drug Administration.
Connection Strength
0.744
-
The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis. Clin J Am Soc Nephrol. 2010 Apr; 5(4):553-6.
Score: 0.361
-
Anemia of chronic kidney disease: CHOIR and the FDA. Nat Clin Pract Nephrol. 2007 Aug; 3(8):406-7.
Score: 0.300
-
The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now? Am J Kidney Dis. 2008 Dec; 52(6 Suppl):S5-13.
Score: 0.083